Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate And Amphetamine Sulfate 11534-0191
Product NDC
11534-0191- Manufacturer
- Sunrise Pharmaceutical, Inc.
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- July 4, 2018
- Listing Expires
- December 31, 2026
- Application
- ANDA209799
Active Ingredients
| Ingredient | Strength |
|---|---|
| Amphetamine Aspartate Monohydrate | 1.875 mg/1 |
| Amphetamine Sulfate | 1.875 mg/1 |
| Dextroamphetamine Saccharate | 1.875 mg/1 |
| Dextroamphetamine Sulfate | 1.875 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulant [EPC]Central Nervous System Stimulant [EPC]
Packaging Options(2)
100 TABLET in 1 BOTTLE (11534-191-01)
1000 TABLET in 1 BOTTLE (11534-191-03)